LifeMD, Inc. — Director's Dealing 2017

Nov 3, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Immudyne, Inc. (IMMD)
CIK: 0000948320
Period of Report: 2017-10-26

Reporting Person: Schreiber Justin (Director, President, Immudyne PR, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-10-26	Common Stock, par value $0.01	P	2700	$0.4145	Acquired	1832972	Indirect
2017-11-03	Common Stock, par value $0.01	J	135721	$0.23	Acquired	1968693	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-11-03	Warrant	$0.4	J	67861	Acquired	2019-11-03	Common Stock, par value $0.01 (67861)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.01	1375000	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrant	$0.4	2019-01-01	Common Stock, par value $0.01 (591745)	591745	Indirect
Warrant	$0.4	2018-11-01	Common Stock, par value $0.01 (217391)	217391	Indirect

Footnotes

F1: Reporting person converted capital contributions to Immudyne PR, LLC pursuant to a subscription agreement. $31,215.94 was converted at $0.23 cents into 135,721 shares and 50% warrant coverage at $0.40.